# An Observational Study of Xeloda (Capecitabine) in Participants With Metastatic or Advanced Breast Cancer

> **NCT01725386** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 274 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT01725386
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 274 (ACTUAL)
- **Last updated:** 2016-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01725386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01725386, "An Observational Study of Xeloda (Capecitabine) in Participants With Metastatic or Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01725386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*